HIGHLIGHTS
- who: David Mengel et al. from the Laboratory for Neurodegenerative Research, Ann Romney Center for Neurologic Diseases, Brigham and Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany have published the research: NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression, in the Journal: Cells 2021, 3514 of /2021/
- what: This study investigates the diagnostic and prognostic potential of different forms of in biofluids from patients with Creutzfeldt-Jakob disease (CJD). Given the incompatibility of MR-tau assays with GuHCl, and the high sensitivity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.